Catch up on the most well-viewed prostate imaging content from 2024.
As we come to the end of 2024, we take a look back at the most well-read prostate imaging content with topics ranging from predictive factors for metastatic prostate cancer to the use of prostate MRI for active surveillance and PSMA PET/CT-guided radiotherapy for oligometastatic prostate cancer. Review the slideshow below to see highlighted prostate imaging content from the past year.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
July 22nd 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.
FDA Clears Point-Of-Care Ultrasound Platform and AI Software for Neuraxial Procedures
July 17th 2025The dual FDA clearances for the Accuro 3S point-of-care ultrasound device and the SpineNav-AI machine learning-based software may enhance precision and safety with ultrasound-guided neuraxial procedures.